Trials / Unknown
UnknownNCT02685449
Insulin Requirement for Pure-protein Meal in Children With Type 1 Diabetes on Insulin Pumps.
Insulin Requirement for Pure- Protein Meal in Children With Type 1 Diabetes Treated With Continuous Subcutaneous Insulin Infusion - a Cross-over, Randomized Trial.
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 70 (estimated)
- Sponsor
- Medical University of Warsaw · Academic / Other
- Sex
- All
- Age
- 10 Years – 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a randomized, cross-over study. The aim of this study is to compare the post-prandial glycaemic variability after pure protein meal following with an administration of square-wave bolus of meal-insulin or without any meal-insulin bolus on the other day. Prolonged post-prandial glycaemic variability will be identified using the self-monitoring of blood glucose (10-point curve) and CGMS.
Detailed description
The square-wave bolus (for meals rich in fat and/or protein) is evenly delivered over several hours as programmed by the patient. The required insulin dose will be calculated based on patient's insulin-exchange ratio. Pure protein meal will be given 3 hours after a first breakfast. To provide the minimal impact of the previous breakfast, all patients will receive up to 120 kcal of carbohydrates and \<100 kcal from protein and fat for the first breakfast (without any extended bolus) Patients receive a standardized pure protein meal at a second breakfast time. Meal insulin will be given as a square bolus or no meal -insulin will be given at all. The 5h post-meal glucose excursions will be recorded by self-blood glucose measurements (SMBG) (every 30 minutes) and continuous glucose monitoring system (CGMS). The intervention is taking part under in-patient clinical conditions.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Insulin glulisine | A kind of study bolus insulin will be insulin aspart if participant used insulin aspart before entering the trial |
| DRUG | Insulin aspart | A kind of study bolus insulin will be insulin lispro if participant used insulin lispro before entering the trial |
| DRUG | Insulin lispro | A kind of study bolus insulin will be insulin lispro if participant used insulin lispro before entering the trial |
Timeline
- Start date
- 2016-02-01
- Primary completion
- 2018-02-01
- Completion
- 2018-08-01
- First posted
- 2016-02-18
- Last updated
- 2016-07-29
Locations
1 site across 1 country: Poland
Source: ClinicalTrials.gov record NCT02685449. Inclusion in this directory is not an endorsement.